Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,276.00    20.00 (1.59%)
Bid:
1,284.00
Ask:
1,292.00
Spread: 8.00 (0.623%)
Market Cap: £584.74m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

AGM Statement

11 Sep 2012 07:00

RNS Number : 9363L
Cohort PLC
11 September 2012
Β 

ο»Ώ

11 September 2012 AIM: CHRT

PRESS RELEASE

COHORT PLC ("Cohort")

AGM Statement & First Quarter Update

Cohort, the independent technology group, is today holding its Annual General Meeting. The Chairman, Nick Prest, will make the following remarks to the meeting:

Β 

"Cohort continued to improve its performance last year, achieving a record trading profit and increasing its order book and net funds. All of Cohort's businesses improved their trading performance with MASS achieving another record result, SCS growing its profitability in a tight market and SEA making progress.

"The combination of a good order book, strong net funds and businesses with operational momentum provide a solid foundation for the current financial year. We have continued to build on this foundation with the contract wins that we have announced over the summer:

Β·; SEA's four year, Β£10 million research contract from the UK Government's Defence Science and Technology Laboratory under a program known as Delivering Dismounted Effect (DDE); and,

Β 

Β·; MASS's multi million pound five-year extension to its managed IT service contract for the Sentry Whole Life Support Programme (WLSP).

"These contracts are a welcome vote of confidence in the capabilities of our businesses and our partnering approach to service provision. Although the UK defence market remains tight, the Cohort businesses' strong and relevant capabilities are leading to a good pipeline of new opportunities with the MOD and in export markets. As at 31 July 2012 the Group order book stood at Β£111m (30 April 2012: Β£107.1m).

"Cohort's trading and prospects at this early stage of the year are consistent with making further progress in 2012/13.

"Although working capital has increased to support project activity at MASS and SEA, the Group has maintained a strong cash balance in excess of Β£12m as at 10 September 2012 (30 April 2012: Β£14.1m). This is enabling the Group to consider acquisitions where suitable opportunities arise, whilst continuing to focus on organic growth and operational improvements. In combination these are intended to deliver increased shareholder value."

Ends

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Β 

Simon Walther, Finance Director

Β 

Investec Bank Plc

020 7597 5970

Keith Anderson / Daniel Adams

Β 

MHP Communications Limited

020 3128 8100

Reg Hoare / Vicky Watkins

Β 

Β 

NOTES TO EDITORS

Β 

Cohort plc (www.cohortplc.com) is the parent company for three innovative, agile and responsive businesses working primarily for defence (air, land and sea), wider government and industry clients.Β 

Β·; SCS (www.scs-ltd.co.uk) - a defence consultancy, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006.Β 

Β 

Β·; MASS (www.mass.co.uk) - a specialist defence and aerospace business, focused mainly on electronic warfare, information systems and electronic systems development. Acquired by Cohort in August 2006.Β 

Β 

Β·; SEA (www.sea.co.uk) - an advanced surveillance systems and software house with hardware development capability operating in the defence, space and transport market sectors. Acquired by Cohort in October 2007.Β 

Β 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and, through its operating companies, employs in total around 530 core staff there and at bases in Bristol, Cambridgeshire, Lincolnshire and Somerset.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMSFAFMSFESEEU
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.